Esma R.Isenović
Institute Vinca, P.O.Box 522, Phone: +38111806-68-68, mob:+381637029163.
EDUCATION:
Post-doctoral visiting scientist , Metabolic Research Unit, University of California, San Francisco,
CA, USA; 1997-1997.
Post-doctoral fellow. Hypertension and Research Division, HenryFordHospital, Detroit, Michigan, USA;1998-2000.
Ph. D. (Molecular Biology), Faculty of Natural Sciences and Mathematics, University of
Belgrade,Yugoslavia; 1992-1996.
M.Sci. (Molecular Biology), Faculty of Natural Sciences and Mathematics, University of Belgrade, Yugoslavia; 1987-1992.
B.Sc. (General Biology), Faculty of Natural Sciences and Mathematics, University of Belgrade, Yugoslavia; 1982-1987.
PROFESSIONAL APPOINTMENTS
Teaching experiences:
Instructor for Biochemistry Course, Faculty of Natural Science, Group for Molecular Biology, University of Belgrade, Yugoslavia. 1986-1987.
Teaching assistant for Biochemistry Course, Faculty of Natural Science, Group for Molecular Biology, University of Belgrade, Yugoslavia; 1986-1987.
Assistant Professor Research Department of Medicine, SUNY-HSC at Brooklyn, Brooklyn, NY; 200-2003.
Associate Professor Research; Institute Vinca Belgrade, 2004-2006.
Visiting Research Assistant Professor University of Illinois at Chicago, Department of Medicine, Chicago, USA, 2006-2007.
Professor (Research) Institute Vinca, 2007-till now
Research Experience:
Visiting Professor, The Pharmaceutical Research Institute at Albany, AlbanyCollege of Pharmacy and Health Sciences, One Discovery Drive, Rensselaer, New York12144, 2010-2010.
Visiting Professor , CNRS UMR 7131 & Univ Pierre and Marie Curie, Hôpital Broussais, Paris, France; CNRS UMR 7131 & Univ Pierre and Marie Curie, Hôpital Broussais, Paris, France; 2008-2008.
Tenure position-Professor (Research), Head of Laboratory for Endocrinology, Hypertension and
Metabolic Diseases, Institute Vinca, Department of Molecular genetics and radiobiology, Belgrade,
Serbia; 2007-current.
Visiting Research Assistant Professor, University of Illinois at Chicago, Department of Medicine, Chicago, USA; 2006-2007.
Visiting Professor , CNRS UMR 7131 & Univ Pierre and Marie Curie, Hôpital Broussais, Paris, France; 2006.
CNRS UMR 7131 & Univ Pierre and Marie Curie, Hôpital Broussais, Paris, France; 2006-2006.
Visiting scientist, Institute of Pathological Physiology, University of Ljubljana, Laboratory for Neuroendocrinology-Molecular Cell 2005-2005 Physiology, Ljubljana , Slovenia; 2005-2005.
Tenure-truck position-Associate Professor (Research), Institute Vinca, Belgrade, Department for
Radioisotopes, Serbia; 2004-2006.
Research Assistant Professor, Principal Research Scientist, Department of Medicine, SUNY-HSC at
Brooklyn, Brooklyn, NY, USA; 2000-2003.
Tenure-track position-Assistant Professor (Research), Institute Vinca, Department for radioisotopes,
Belgrade, Serbia; 1998-2003.
Research Scientist, Institute Vinca, and Department for molecular biology and endocrinology,
Belgrade, Serbia; 1998-2000,
Postgraduate fellowship, Centre International de Formation en Biotechnologie, Bussières-Badil, France, 1990-1990
HONORS AND AWARDS
The first prize –The best presentation of the best technological innovation. Ministry of Sciences Serbia, 2008
Award from LCG Promochem GmBH for the seminarian: Env. /Food, solvent PTS seminarian by LGS Promochem GmBH, 2007.
Republic of Serbia, Award for the workshop-Training-Planning of Business, 2006.
Compotency based Economies through Formation of Enterprise (CEFE) supported by GermanCenter for Technical Cooperation-Award for CEFE training-Manager (completed 1st module of training), 2005.
European co-operations in the field of scientific and technical research-COST. Grant Award for short-term Scientific mission (STMS), 2005.
NIH postdoctoral fellowship.NIH, USA, 1998.
InternationalCenter for Genetic Engineering and Biotechnology, ChinaNationalCenter for
Biotechnology, Development, Beijing, China Scholarship for postgraduate education,
1995.Foundation for Open Society “George Soros “International Conference of
Biochemistry and Molecular Biology, San Francisco, CA, Travel Award, 1996.
Centre International de Formation en Biotechnologie, Bussiere-Badil, France, Scholarship for postgraduate
Education,1990. Service Committees:Member of College of Medicine Interviewer Committee, SUNY at
Brooklyn, Division of Student Affairs, 2000- 2003.
Served on the faculty of the SUNY at Brooklyn Graduate School.2003-2003
Member of Management Committee for COST action B17. 2005-2007
Member of Scientific Board for Grant Revision for Ministry of Science, Serbia. 2005
Member of Scientific Board in Vinca Institute, Belgrade, Serbia. 2005-2008
Member of The Science Advisory Board 2007-present
Member of Management Committee for COST action MBE0602. 2007-present
President of Board for environment protection and health ( Vinca Institute) 2007-present
European Science Foundation ( 2006-present)Member of Management Committee for COST action CM0602. 2009-present
Member of Board for education, Institute Vinca. 2010-present
Consultant Member of society of studying cardiovascular diseases, SOS-CVD, 2010-present
Member of Network Active in Diabetes Prevention
Member of Scientific Board in Vinca Institute, Belgrade, Serbia. 2010-
Member of 2011 Awards Review Committee-Endocrine Society.2011-
TRAINEES:
Production of Monoclonal Antibodies, Centre International de Formation en Biotechnologie, Bussiere-Badil
France, 1990.
Course for radioisotope, HenryFordHospital, Detroit, Michigan, USA, 1999.
HIPAA Compliance for the year 2003: Health Care Compliance Strategies, INC, NY, and USA2003.
Annual ethics training, University of Illinois at Chicago, Chicago, USA 2006
1st Course of Clinical Endocrinology, Belgrade, march 17th, 2006, European Society of 2006Endocrinology
Env. /Food, solvent PTS seminarium by LGS Promochem 2007
PROJECT PARTICIPATION (& MENAGEMENT: )
Current:
PI: Ministry of Science of Republic Serbia:Hormonal regulation of expression and activity of the sodium-potassium pump and nitric oxide synthase in experimental models of insulin resistance, diabetes and cardiovascular disorders.2011-2014.
Co-PI: Ministry of Science of Republic Serbia:An integral study to identify the regional genetic and environmental risk factors for the common noncommunicable diseases in the human population of Serbia-INGEM-S. 2011-2014.
PI: Ministry of Science of Republic Serbia: Molecular mechanisms of transduction of hormone signals: Biological markers of modifications and integrations of signaling pathways in physiological and pathophysiological conditions”2005-2010.
Member : EU coperation Grant COST BM 0602: ”Adipose Tissue: A Key Target for Prevention of the
Metabolic Syndrome”.2007-2011.
Member: EU coperation Grant COST CM 0602: action CM0602: „Inhibitors of angiogenesis: design, synthesis and biological exploitation“ (ANGIOKEM) 2007-2011.
Previous:
PI: Collaborative Grant with CNRS UMR, Univ P& M Curie, Paris (Dr. P. Marche),“Insulin-like
Growth Factor-1 (IGF-1) Regulation of Nitric Oxide Synthase (NOS) and Sodium Pump in Type 1
Diabetes “2005-2008.
PI: Collaborative Grant with University of Ljubljana (Prof. R. Zorec) “Response to insulin on cellular
level”, 2005-2008.
Co-Investigator.: NIH (1 R01): “Neurobiology of Sleep Apnea in Aging”, 2006-2007.
Co-Member: : EU coperation Grant COST B17:“Obesity and Diabetes mellitus in the Elderly”, 2004-
2006.
Co-Member: European Commission Framework Programme: Equal Project (EC4): Multi-National External Quality Assay (EQA) Programmes in Clinical Molecular Diagnostics based on Performance and Interpretation of PCR assay including dissemination and training, supported by the European Community within the FP6 Programme.2004-2006.
Co-Investigator: Ministry of Science Serbia (No: 2011) “Genetic epidemiology of vascular diseases “, 2004-2005.
Co-Investigator: Ministry of Science Serbia (No.1980) “Investigation and developing radiopharmaceuticals for medical Application”, 1998-2003.
PI: Pilot Project Program, Dean’s Initiative in Research Investment, “Vascular Interaction of
Estradiol and IGF-1 in Insulin Resistance”, 2000-2003.
Co-Investigator: NIH (1 R01 HL66119-01) “Ang II and IGF-1 Interaction in Cardiovascular Tissue”,
2000-2003.
Co- Investigator: NOVARTIS: “Effect of Inhibition of the Renin Angiotensin System (RAS) on
Insulin Sensitivity In Vascular Smooth Muscle Cells (VSMC) and Endothelial Cells (EC): Valsartan
Effects on Insulin Mediated Nitric Oxide Production, Sodium Pump Activation and Glucose
Transport”, 2001-2003.
Co- Investigator: NIH (1 R01) “Ang II Opposes Insulin Mediated Vasorelaxation and Glucose
Utilization: Role of ROS and RhoA”, 2003-2003
Co- Investigator: VA Merit Review “Vascular Protein Kinase B/Akt and Rho Signaling”, 2002-2003.
Pending
PI: Collaborative Grant with University of Patras Medical School, Greece, (Prof. Kyriakos E. Kypreos) “Role of apolipoprotein A-I in diet induced obesity and related metabolic perturbations”, 2011-2012.
PROFESSIONAL SOCIETIES
Serbian Society of Biology (1998-current); The Endocrine Society (2001-2007);American Diabetes Association (2001-2002);American Heart Association (2001-2002);Serbian Society of Nuclear Medicine (2004-2005);Serbian Society of Chemistry (2004-2006 );COST (European co-operation in the field of scientific and technical research (2005-current);American Association for the Advancement of Science (2001-2007);
Humane Society of the United States (2000- );American Chemical Society (2007);The Science Advisory Board –USA ( 2007- );Serbian Society of Medical Doctors (2008-2009)
Service Committees: Member of College of Medicine Interviewer Committee, SUNY at Brooklyn, Division of Student Affairs, 2000- 2003., Served on the faculty of the SUNY at Brooklyn Graduate School.2003-2003, Member of Management Committee for COST action B17. 2005-2007, Member of Scientific Board for Grant Revision for Ministry of Science, Serbia. 2005, Member of Scientific Board in Vinca Institute, Belgrade, Serbia. 2005-2008, Member of The Science Advisory Board 2007-present, Member of Management Committee for COST action MBE0602. 2007-present , President of Board for environment protection and health ( Vinca Institute) 2007-2010, European Science Foundation ( 2006-present),Member of Management Committee for COST action CM0602. 2009-present ,Member of Board for education, Institute Vinca. 2010-present,Consultant Member of society of studying cardiovascular diseases, SOS-CVD, 2010-present,Member of Network Active in Diabetes Prevention,Member of Scientific Board in Vinca Institute, Belgrade, Serbia. 2010-,Member of 2011 Awards Review Committee-Endocrine Society.2011-
EDITORIAL BOARDS:Materia Medica;The Open Atherosclerosis & Thrombosis Journal;Journal of Diabetes and Endocrinology’Endocrinology Studies
REVIEWEr :American Journal of Physiology (section: Endocrinology and Metabolism),Growth Hormone & IGF Research,Diabetes Research and Clinical PracticeBiological Procedures Online,Pharmacology Research ,Cell Biology International ,Journal of Pharmacy and Pharmacology,International Journal of Cardiology,Journal of Bacteriology Research,African Journal of Pharmacy and Pharmacology ,Angiology - Journal of Vascular Biology,General Physiology and Biophysics,Pharmacology and Therapeutics,Journal of Physiology and Biochemistry,Clinical and Experimental Pharmacology and Physiology,The Journal of Rheumatology.African Journal of Biochemical Research .Journal of Diabetes and Its Complications.TheScientificWorld.The Open Atherosclerosis & Thrombosis Journal.Endocrinology Studies.Journal of Medicine and Medical Sciences.Hepatitis Monthly.African Journal of Biotechnology.Journal of Receptor, Ligand and Channel Research,Research and Reports in Biochemistry,Research and Reports in Endocrine Disorders,Research Reports in Clinical Cardiology
REVIEWED GRANT PROPOSALS FOR:Ministry of Science, (Serbia) -2006,Ministry of Science, (Serbia) -2010,Endocrine Society-Summer Research Fellowship Awards-2011.
PAPERS & MEETING REPORTS: 57 (international) and 21 domestic
Citated up to June 2010, more than 250 times
SELECTED PUBLICATIONS( from total of 85):
1.Sanja S. Soskić, , Branislava D. Dobutović, Emina M. Sudar, Milan M. Obradović, Dragana M. Nikolić, Božidarka L. Zarić, Srđan Đ. Stojanović, Edita J. Stokić, Dimitri P. Mikhailidis, and Esma R. Isenović (2011). The peroxisome proliferator-activated receptors and atherosclerosis.Angiology-Journal of Vascular Biology (in press)
2.Ibrahim M. Ibrahim, Nermeen A. Bastawy, Moshira A. Rateb , Mohamed A Haidara,Ismaeel M Bin-Jaliah , Fahaid Al-Hashim, Mohammed M Dallak, Sanja Soskic and Esma R. Isenovic. (2011): Effect of insulin resistance, plasma adiponectin level and AdipoR1 expression in the skeletal muscles of STZ-treated High-Fat rats. J of Helath Sciences(accepted)
3.Andreja Trpkovic, Edith Stokic, Djordje Radak, Zoran Gluvic,Mohamed Haidara, Mousa S, Dimitri P. Mikhailidis, Esma. R. Isenovic(2011) : Chronic Hepatitis C, Insulin Resistance and Vascular Disease.Curr Pharm 16(34):3823-9.
4.Goran Koricanac; Snezana Tepavcevic; Zorica Zakula; Tijana Milosavljevic; Mojca Stojiljkovic; Esma R Isenovic (2011): Interference between insulin and estradiol signaling pathways in the regulation of cardiac eNOS and Na+/K+-ATPase .European Journal of Pharmacology. (in press )
5.Slobodan Tanaskovic , Esma .R Isenovic , Djordje Radak (2011):Inflammation As A Marker For The Prediction Of Internal Carotid Artery Restenosis Following Eversion Endarterectomy -Evidence From Clinical Studies , Angiology-Journal of Vascular Biology (in press)
6.Esma R. Isenović, Sanja Soskić, Andreja Trpković, Branislava Dobutovic,Milan Popović, ,Zoran Gluvić, Biljana Putniković, and Pierre Marche (2011): Insulin, Thrombine, ERK1/2 Kinase And Vascular Smooth Muscle Cells Proliferation . Current Pharmaceutical Design. 16(35):3895-902.
7.Zakula, Zorica, Koricanac, Goran, Tepavcevic, Snezana, Stojiljkovic, Mojca, Milosavljevic, Tijana and Isenovic R. Esma (2011): Fructose-Rich Diet Induces Cardiac Insulin Resistance In Ovariectomized Female Wistar Rats. N. Europen J of Nutrition(in press)
8.Khaled Abou El Fadl, Nivine Ragy, Heba Sedrak, Mona El Batran, Rania Khalifa, Neemat Kassem andEsma R.Isenovic (2011): Periodontitis and Cardiovascular disease: "Floss and reduce a potential risk factor for CVD", Angiology-Journal of Vascular Biology. 62(1):62-7.
9.Mohamed A. Haidara,Hanaa Z.Yassin,Zorica Zakula, Dimitri P. Mikhailidis and Esma R. Isenovic(2010): Diabetes and antioxidants: myth or reality? Current vascular pharmacology 8(5):661-72.
10.Mohamed A Haidara, Mohamed D. Morsy, Hesham A. Abdel-Razek, Dimitri P. Mikhailidis and Esma R. Isenovic(2010): Effects Of L-Canavanine And Ozone On Vascular Reactivity In Septicemic Rats. J of Physiology and Biochemistry 66 (3):255-264
11.Emina Sudar, Branislava Dobutovic, Sanja Soskic, Zorica Zakula, Maja Misirkic, Ljubica Vucicevic, Kristina Janjetovic, Vladimir Trajkovic, Dimitri P. Mikhailidis and Esma R. Isenovic. (2010): Regulation of iNOS Activity/Expression In Rat Heart isolated from Ghrelin treated Rats. J of Physiology and Biochemistry. (in press)
12.Bitar MS, Ayed AK, Abdel-Halim SM, Isenovic ER, Al-Mulla F.(2010): Inflammation and apoptosis in aortic tissues of aged type II diabetes: Amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase/Akt- dependent mechanism. Life Sciences 86: 844-853.
13.Esma R. Isenović, Mamdouh H. Kedees, Mohamed A. Haidara, Andreja Trpkovic, Dimitri P. Mikhailidis, and Pierre Marche (2010): Involvement Of ERK1/2 Kinase in Insulin And Thrombin Stimulated Vascular Smooth Muscle Cell Proliferation . Angiology-Journal of Vascular Biology. 61(4):357-64
14.Hanan H. Fouad,Husain . Al- Dera, Sameh W. Bakhoum, Laila A. Rashed, Rehab H.Sayed , Moshira A. Rateb, Mohamed A. Haidara, Sanja Soskic, and Esma R. Isenovic (2010): Levels of sCD40 Ligand in Chronic and Acute Coronary Syndromes and its Relation to Angiographic Extent of Coronary Arterial Narrowing. Angiology-Journal of Vascular Biology . 61(6):567-573.
15.Ismaeel Bin-Jaliah, Hania I. Ammar,Dimitri P. Mikhailidis, Mohammed A. Dallak, Fahaid H. Al-Hashem, Mohamed Haidara, Hanaa Z. Yassin, Abeer A .Bahnasi , Laila A. Rashed , Esma R. Isenovic (2010): Cardiac adaptive responses afterhypoxia in an experimental model. Angiology-Journal of Vascular Biology . 61(2):145-156.
16.Esma R. Isenović, Mamdouh H. Kedees, Snežana Tepavčević, Tijana Milosavljević, Goran Korićanac , Andreja Trpković and Pierre Marche (2009): Role of PI3K/AKT, cPLA 2 and ERK1/2 signaling pathways in inuslin regulation of vascular smooth muscle cells proliferation. Cardiovascular& Hematological Disorders-Drug Targets . 9:3:172-180.
17.Sudar E, Dobutovic B,Milosavljevic T, Putnikovic B, Gluvic Z, Isenovic RE.(2009) : Interactiveeffectsofinsulinandβ-EstradiolonproteinkinaseBphosphorylationinadultratcardiomyocytes.ActaChimicaSlovenica, 56,354-358.
18.Isenovic ER, Faud M, Koricanac G, Sudar E, Velebit J, Dobutovic B, Marche P.(2009): Insulin regulation of proliferation involves activation of Akt and ERK 1/2 signaling pathways in vascular smooth muscle cells. Experimental and Clinical Endocrinology & Diabetes ,116:1-6.
19.Koricanac G, Milosavljevic T, Stojiljkovic M, Zakula Z, Tepavcevic T, Ribarac-Stepic N, Isenovic RE. (2009): Impact of estradiol on insulin signaling in rat heart.Cell Biochemistry and Function27, 102-10.
20.Isenovic RE, Fretaud M, Dobutovic B, Sudar E, Smiljanic K, Zaric B, Trpkovic A, Marche P. (2009): Novel hypothesis with respect to a possible involvement of cytosolyc phospholipase 2 in insulin–stimulated proliferation of vascular smooth muscle cells. Cell Biol Int. 33, 386-392.
21.Koricanac, G., Milosavljevic,T., Stojiljkovic, V., Zakula, Z., Ribarac-Stepic, N. and Isenovic, R.E. (2008): Insulin signaling in the liver and uterus of ovariectomized ratstreated with estradiol. The Journal of Steroid Biochemistry &Molecular Biology, 108, 109-116.
22.Sudar, E., Velebit, J., Gluvic, Z., Zakula, Z., Lazic,E., Vuksanovic-Topic, Lj., Putnikovic, B., Neskovic, A. and Isenovic, R.E.(2008): Hypothetical Mechanism Of Sodium Pump Regulation By Estradiol Under Primary Hypertension. The Journal of Theoretical Biology, 251, 584-592.
23.Esma, R., Isenovic, Andreja, Trpkovic., Zorica, Zakula., Goran, Koricanac., and Pierre, Marche. (2008): Role of ERK1/2 Activation In Thrombin-Induced Vascular Smooth Muscle Cell Hypertrophy. Current Hypertension Reviews, 4, 190-196.
24.Jelena, Velebit., Petra, Brina, Kovačič., Mateja, Prebil., Helena, H., Chowdhury., Sonja, Grilc., Marko, Kreft., Joergen, Jensen., Esma R. Isenović., Robert, Zorec. (2008): Rosiglitazone Modulates Insulin-Induced Plasma Membrane Area Changes in Single 3T3-L1 Adipocytes. J Membrane Biology. 223,141-149.
25.Tepavcevic, S. Isenovic, R.E.and Milovanovic, S. (2008): Regulation of longitudinal muscle contraction by nitric oxide donor sodium nitroprusside. De Pharmazie, 63, 51-155.
26.Zakula, Z., Koricanac, G., Markovic, Lj., Putnikovic, B. and Isenovic, R.E.( 2007): Regulation of the inducibile nitric oxide synthase and sodium pump in type 1 diabetes. Medycal Hypotheses 69, 302-306.
27.Isenovic, R.E., Meng, Y., Jamali, N., Milivojevic, N. and Sowers, J.R. (2004): Ang II attenuates IGF-1-stimulated Na+, K+-ATPase activity via PI3K/Akt pathway in VSMC. Int. J. Mol. Med. 13, 915-922.
28.Isenovic, R.E., Jacobs, D., Keedess, M., Sha, Q., Milivojevic, N., Kowakami, K., Gick, G and Sowers, J.R. (2004): Ang II Regulation of the Sodium Pump Involves the PI3K and p42/44 MAPK Signaling Pathways in VSMC. Endocrinology 145, 1151-1160.
29.Isenovic, R.E., Divald, A., Milivojevic, N., Grgurevic, T., Fisher, S.E. and Sowers, J.R. (2003): Interactive effects of insulin- likes growth factor-1 and beta-estradiol on eNOS activity in rat aortic endothelial cells. Metabolism 53, 482- 487.
30.Isenovic, R.E., Meng, Y., Divald, A., Milivojevic, N. and Sowers, J.R. (2003): Role of PI3K/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells. Endocrine 19, 287-291.
31.Blendae, M.C., McFarlane, S., Isenovic, R.E., Gick, G. and Sowers, J.R. (2003): Heart disease in Diabetics. Curr. Diab. Rep. 3, 223-229.
32.Vulovic, M., Koricanac, G., Isenovic, R.E. and Ribarac-Stepic, N. (2003): Age-dependent alterations of glucocorticoid receptors and relatiuonship to enzyme activities in rat liver. Arch.Biol.Sci. 55, 1-2.
33.McFarlane, S.I., Isenovic, R.E.,Winer, N. Kirpichnikov, D., Sowers, J. (2002): Alterations in cardiovascular metabolism in the cardiometabolic syndrome.In: Calcium antagonists in clinical medicine (Ed. Epstein M), Hanley&Belfus, INC 33-39.
34.Isenovic, R.E.,Walsh, M.F., Muniyappa, R., Bard, M., Diglio, C.A. and Sowers, J.R. (2002): Phosphatidylinositol 3-Kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production. Metabolism 51, 380-386.
35.Isenovic, R.E., Muniyappa, R., Milivojevic, N., Rao, J. and Sowers, J.R. (2001): Role of PI3-kinase in isoproterenol and IGF-1 induced ecNOS activity. Biochem. Biophys. Res. Commun. 285, 954-958.
36.Ribarac-Stepic, N.,Isenovic, E., Naumovic, R., Koricanac, G., Vulovic, M., Zakula, Z., Blagojevic, R. and Djukanovic, R. (2001): Glucocorticoid receptors in lymphocytesand stability of kidney graft function. Clin Exp Med. 4,179-86.
37.Isenovic, E., LaPointe, M. (2000): Role of Ca++ phospholipase A2 on regulation of inducible nitric oxide synthase. Hypertension 35, 249-254.
38.LaPointe, M., Isenovic, E.(1999): Interleukin-1ß regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33, 276-282.
39.Djurica, S., Milosevic, D., Milanovic, P., Tosic, G., Isenovic, E., Markovic, O. and Ribarac-Stepic, N. (1998): Cortisol of serum and glucocorticoid receptors in normal and pathophysiological aging. Gerantologija 1, 179-185.